Vanguard Group
NBY icon

Vanguard Group’s NovaBay Pharmaceuticals NBY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,710
Closed -$1.44K 4430
2024
Q1
$1.44K Hold
13,710
﹤0.01% 4447
2023
Q4
$2.8K Buy
+13,710
New +$2.8K ﹤0.01% 4493
2023
Q1
Sell
-10,673
Closed -$20.8K 4566
2022
Q4
$20.8K Sell
10,673
-580,915
-98% -$1.13M ﹤0.01% 4493
2022
Q3
$65K Hold
591,588
﹤0.01% 4523
2022
Q2
$148K Hold
591,588
﹤0.01% 4502
2022
Q1
$175K Hold
591,588
﹤0.01% 4553
2021
Q4
$223K Buy
591,588
+106,555
+22% +$40.2K ﹤0.01% 4547
2021
Q3
$312K Hold
485,033
﹤0.01% 4439
2021
Q2
$326K Buy
485,033
+71,492
+17% +$48.1K ﹤0.01% 4323
2021
Q1
$376K Buy
413,541
+253,317
+158% +$230K ﹤0.01% 4175
2020
Q4
$112K Buy
160,224
+7,915
+5% +$5.53K ﹤0.01% 4136
2020
Q3
$111K Buy
152,309
+32,085
+27% +$23.4K ﹤0.01% 4008
2020
Q2
$138K Buy
120,224
+50,100
+71% +$57.5K ﹤0.01% 3961
2020
Q1
$42K Buy
70,124
+38,398
+121% +$23K ﹤0.01% 4008
2019
Q4
$20K Buy
31,726
+400
+1% +$252 ﹤0.01% 4090
2019
Q3
$19K Buy
31,326
+1,400
+5% +$849 ﹤0.01% 4130
2019
Q2
$51K Sell
29,926
-2,414
-7% -$4.11K ﹤0.01% 4107
2019
Q1
$39K Buy
32,340
+2,811
+10% +$3.39K ﹤0.01% 4075
2018
Q4
$23K Buy
29,529
+2,619
+10% +$2.04K ﹤0.01% 4113
2018
Q3
$51K Hold
26,910
﹤0.01% 4125
2018
Q2
$67K Sell
26,910
-1,420
-5% -$3.54K ﹤0.01% 4085
2018
Q1
$98K Buy
28,330
+12,820
+83% +$44.3K ﹤0.01% 4034
2017
Q4
$59K Sell
15,510
-13,503
-47% -$51.4K ﹤0.01% 4025
2017
Q3
$134K Buy
29,013
+2,451
+9% +$11.3K ﹤0.01% 3969
2017
Q2
$102K Buy
26,562
+1
+0% +$4 ﹤0.01% 3983
2017
Q1
$98K Hold
26,561
﹤0.01% 3990
2016
Q4
$88K Hold
26,561
﹤0.01% 3985
2016
Q3
$110K Buy
26,561
+8,738
+49% +$36.2K ﹤0.01% 3973
2016
Q2
$45K Hold
17,823
﹤0.01% 4085
2016
Q1
$38K Sell
17,823
-21,124
-54% -$45K ﹤0.01% 4092
2015
Q4
$79K Sell
38,947
-934,736
-96% -$1.9M ﹤0.01% 4100
2015
Q3
$273K Sell
973,683
-9,525
-1% -$2.67K ﹤0.01% 3982
2015
Q2
$610K Buy
983,208
+135,456
+16% +$84K ﹤0.01% 3811
2015
Q1
$585K Buy
847,752
+5,100
+0.6% +$3.52K ﹤0.01% 3786
2014
Q4
$531K Buy
842,652
+2,890
+0.3% +$1.82K ﹤0.01% 3708
2014
Q3
$705K Buy
839,762
+49,379
+6% +$41.5K ﹤0.01% 3609
2014
Q2
$624K Buy
790,383
+47,520
+6% +$37.5K ﹤0.01% 3620
2014
Q1
$869K Buy
742,863
+25,300
+4% +$29.6K ﹤0.01% 3500
2013
Q4
$883K Buy
717,563
+269,960
+60% +$332K ﹤0.01% 3450
2013
Q3
$765K Buy
447,603
+104,758
+31% +$179K ﹤0.01% 3437
2013
Q2
$473K Buy
+342,845
New +$473K ﹤0.01% 3497